EDGAR Filing Documents for 0000950135-07-001693

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0000950135-07-001693

Filing Date

2007-03-16

Accepted

2007-03-16 16:54:08

Documents

Period of Report

2006-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	CRITICAL THERAPEUTICS, INC.	b63627cte10vk.htm	10-K	1217831
2	EX-10.8 AMENDMENT NO. 2, DATED JANUARY 8, 2007, TO SPONSORED RESEARCH LICENSE AG	b63627ctexv10w8.txt	EX-10.8	20668
3	EX-10.14 AMENDMENT NO. 1, DATED APRIL 13, 2005, TO LICENSE AGREEMENT	b63627ctexv10w14.txt	EX-10.14	3911
4	EX-10.16 AMENDMENT NO. 1, DATED SEPTEMBER 15, 2004, TO LICENSE AGREEMENT	b63627ctexv10w16.txt	EX-10.16	5615
5	EX-10.38 NON-EMPLOYEE DIRECTOR COMPENSATION AND REIMBURSEMENT POLICY	b63627ctexv10w38.txt	EX-10.38	3816
6	EX-10.42 2007 COMPANY GOALS	b63627ctexv10w42.txt	EX-10.42	1778
7	EX-10.43 CASH BONUSES FOR EXECUTIVE OFFICERS	b63627ctexv10w43.txt	EX-10.43	4116
8	EX-10.44 2007 SALARIES FOR EXECUTIVE OFFICERS	b63627ctexv10w44.txt	EX-10.44	2064
9	EX-10.45 MAXIMUM ANNUAL CASH BONUSES FOR EXECUTIVE OFFICERS	b63627ctexv10w45.txt	EX-10.45	2354
10	EX-10.48 AMENDMENT NO. 2 TO CONSULTING AGREEMENT, AMENDMENT NO. 1 TO APPROVAL AG	b63627ctexv10w48.txt	EX-10.48	21515
11	EX-21.1 SUBSIDIARIES OF THE REGISTRANT	b63627ctexv21w1.txt	EX-21.1	659
12	EX-23.1 CONSENT OF DELOITTE & TOUCHE LLP	b63627ctexv23w1.htm	EX-23.1	1658
13	EX-31.1 SECTION 302 CERTIFICATION OF P.E.O. & P.F.O.	b63627ctexv31w1.htm	EX-31.1	8545
14	EX-32.1 SECTION 906 CERTIFICATION OF P.E.O. & P.F.O.	b63627ctexv32w1.htm	EX-32.1	3309
15	GRAPHIC	b63627ctb6362701.gif	GRAPHIC	7195
16	GRAPHIC	b63627ctb6362702.gif	GRAPHIC	12411
	Complete submission text file	0000950135-07-001693.txt		1326690

Mailing Address 60 WESTVIEW STREET LEXINGTON MA 02421

Business Address 60 WESTVIEW STREET LEXINGTON MA 02421 781-402-5700

CRITICAL THERAPEUTICS INC (Filer) CIK: 0001145404 (see all company filings)

Filing Detail